In the current month, INDP has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. INDP average Analyst price target in the last month is 10.000.
Based on analysts' estimates, INDP EPS is projected to reach -1.460 in FY2026Q3, following reported EPS of -0.015 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.02, while Indaptus Therapeutics IncINDP's earnings per share (EPS) for the previous quarter was USD -0.23. EPS for the next quarter is expected at USD -1.46.